Product How it works Pricing Blog FAQ About Contact
GE HealthCare

GE HealthCare (NASDAQ: GEHC) net income

GE HealthCare reported a net profit of $2,084m for fiscal 2025, 4.6% more than in fiscal 2024 ($1,993m). Its net margin was 10.1%. Earnings per share were $4.56.

Net income, in millions of US dollars1,91620221,56820231,99320242,0842025

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$2,084m+4.6%10.1%$4.56
2024$1,993m+27.1%10.1%$4.37
2023$1,568m−18.2%8.0%$3.05
2022$1,916m—10.4%$4.22

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the net income of GE HealthCare

How much did GE HealthCare earn in fiscal 2025?
GE HealthCare reported a net profit of $2,084m for fiscal 2025. In fiscal 2024 it reported a net profit of $1,993m.
What are the earnings per share of GE HealthCare?
They were $4.56 in fiscal 2025, compared with $4.37 in fiscal 2024.
What is the net margin of GE HealthCare?
In fiscal 2025 its net profit was 10.1% of its revenue.
What was the most profitable year for GE HealthCare?
Of its last 4 fiscal years, fiscal 2025, with $2,084m.
Where do the figures for GE HealthCare come from?
From the annual report (Form 10-K) that GE HealthCare files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that GE HealthCare files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. More on GE HealthCare: the GE HealthCare page · annual accounts · revenue · dividends paid · insider transactions.

Dividend per share of GE HealthCare by fiscal year, with the filing behind every figure: GE HealthCare dividend history.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.